UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934

 

Date of Report (Date of earliest event reported): March 18, 2016

 

PRAXSYN CORPORATION

(Exact name of Registrant as specified in its charter)

 

Nevada   333-130446   20-3191557
(State or other jurisdiction
of incorporation) 		  (Commission
File Number) 		  (IRS Employer
Identification No.)

 

18013 Sky Park Circle, Suite A, Irvine, CA 92614
(Address of principal executive offices, including zip code)
 
(949) 777-6112
(Registrant’s telephone number, including area code)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions:

 

[  ] Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

[  ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

[  ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

[  ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)).

 

 

 

 
 

 

Item 5.02 Departure of Directors or Certain Officers; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

 

Effective March 18, 2016, Ms. Kelly Reynolds resigned as member of the Board of Directors of Praxsyn Corporation, a Nevada corporation (the “Company”). Ms. Reynolds has also resigned as an officer and director of Mesa Pharmacy, a California corporation (“Mesa”) and NexGen Med Solutions, LLC, a Nevada limited liability company (“NexGen”). In addition, as of March 25, 2015, Ms. Reynolds gave notice that she would not be staying on as an employee of the Company, Mesa or NexGen, but instead shall be pursuing other business opportunities.

 

Ms. Reynolds resignation from the aforementioned positions was not due to any disagreement or matter relating to the Company’s operations, policies or practices.

 

 
 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  By: /s/ Edward Kurtz
    Edward Kurtz, Chief Executive Officer

 

Dated: March 28, 2016

 

 
 

 

Praxsyn (CE) (USOTC:PXYN)
Gráfica de Acción Histórica
De Dic 2024 a Ene 2025 Haga Click aquí para más Gráficas Praxsyn (CE).
Praxsyn (CE) (USOTC:PXYN)
Gráfica de Acción Histórica
De Ene 2024 a Ene 2025 Haga Click aquí para más Gráficas Praxsyn (CE).